Atlas FDA

RADIESSE Injectable Implant; RADIESSE Hands; RADIESSE (+) Lidocaine

FDA premarket approval P050052/S167 · decided 2025-04-01

Approval details

PMA number
P050052
Supplement
S167
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
RADIESSE Injectable Implant; RADIESSE Hands; RADIESSE (+) Lidocaine
Generic name
Implant, dermal, for aesthetic use
Applicant
Merz North America, Inc.
Date received
2025-03-03
Decision date
2025-04-01
Days to decision
29 days
Decision code
OK30
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Franksville, WI
Statement
approval for layout modifications of the existing cleanroom

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
DESCRIBE PFD Patch (K172689)Merz North America, Inc.2017-11-29